Docosahexaenoic acid decreases plasma homocysteine via regulating enzyme activity and mRNA expression involved in methionine metabolism

Nutrition

Volumn 26, Issue 1, 2010, Pages 112-119

  Huang, Tao ^a,b   Wahlqvist, Mark L ^a,b,c   Li, Duo ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b APCNS Centre of Nutrition and Food Safety   (China)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Cystathionine synthase; Cystathionine lyase; Fish oil; Gene expression; Hydrogen sulfide; Methionine adenosyltransferase; S adenosylhomocysteine hydrolase

Indexed keywords

ADENOSYLHOMOCYSTEINASE; CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; DOCOSAHEXAENOIC ACID; FISH OIL; HOMOCYSTEINE; HYDROGEN SULFIDE; MESSENGER RNA; METHIONINE; METHIONINE ADENOSYLTRANSFERASE; OLIVE OIL; OMEGA 3 FATTY ACID; PHOSPHOLIPID;

AMINO ACID METABOLISM; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; LIVER; LUNG PARENCHYMA; MALE; NONHUMAN; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; RAT; SALMON; TUNA;

ADENOSYLHOMOCYSTEINASE; ANIMALS; CYSTATHIONINE BETA-SYNTHASE; CYSTATHIONINE GAMMA-LYASE; DOCOSAHEXAENOIC ACIDS; ENZYMES; FISH OILS; GENE EXPRESSION; HOMOCYSTEINE; LIPID METABOLISM; LIVER; LUNG; MALE; METHIONINE; METHIONINE ADENOSYLTRANSFERASE; PLANT OILS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SALMON; TUNA; UP-REGULATION;

RATTUS; SCOMBRIDAE;

EID: 71949093334     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2009.05.015     Document Type: Article

References (52)

1. Arnesen E., Refsum H., Bonna K.H., Ueland P.M., Forde O.H., and Nordrehaug J.E. Serum total homocysteine and coronary heart disease. Int J Epidemiol 24 (1995) 704-709
2. McCully K.S. Vascular pathology of homocysteinemia implication for the pathogenesis of arteriosclerosis. Am J Pathol 56 (1969) 111-128
3. Huang T., Yuan G.F., Zhang Z.G., Zou Z.Q., and Li D. Cardiovascular pathogenesis in hyperhomocysteinemia. Asia Pac J Clin Nutr 17 (2008) 8-16
4. Kaul S., Zadeh A.A., and Shah P.K. Homocysteine hypothesis for atherothrombotic cardiovascular disease, not validated. J Am Coll Cardiol 48 (2006) 914-923
5. Dinleyici E.C., Kirel B., Alatas O., Muslumanoglu H., Kilic Z., and Dogruel N. Plasma total homocysteine levels in children with type 1 diabetes: relationship with vitamin status, methylene tetrahydrofolate reductase genotype, disease parameters and coronary risk factors. J Trop Pediatr 52 (2006) 260-266
6. Sofi F., Marcucci R., Bolli P., Giambene B., Sodi A., Fedi S., et al. Low vitamin B6 and folic acid levels are associated with retinal vein occlusion independently of homocysteine levels. Atherosclerosis 198 (2008) 223-227
7. Gao S., and Tang C.S. The cellular molecular mechanism of hyperhomocysteine in atherosclerosis. Dev Physiol 33 (2002) 335-338
8. Selhub J. Homocysteine metabolism. Annu Rev Nutr 19 (1999) 217-246
9. Hamelet J., Demuth K., Paul J.L., Delabar J.M., and Janel N. Hyperhomocysteinemia due to cystathionine beta synthase deficiency induces dysregulation of genes involved in hepatic lipid homeostasis in mice. J Hepatol 46 (2007) 151-159
10. Refsum H., Ueland P.M., Nygard O., and Vollset S.E. Homocysteine and cardiovascular disease. Annu Rev Med 49 (1998) 31-62
11. Hu F.B., Stampfer M.J., Manson J.E., Rimm E.B., Wolk A., Colditz G.A., et al. Dietary Intake of α-linolenic acid and risk of fatal ischemic heart disease among women. Am J Clin Nutr 69 (1999) 890-897
12. Iso H., Rexrode K.M., Stampfer M.J., Manson J.E., Colditz G.A., Speizer F.E., et al. Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA 285 (2001) 304-312
13. Marchioli R., Barzi F., Bomba E., Chieffo C., Di Gregorio D., Di Mascio R., et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 105 (2002) 1897-1903
14. Erkkila A.T., Lichtenstein A.H., Mozaffarian D., and Herrington D.M. Fish intake is associated with a reduced progression of coronary artery atherosclerosis in postmenopausal women with coronary artery disease. Am J Clin Nutr 80 (2004) 626-632
15. Morris M.C., Sack F., and RosnerDoes fish oil lower blood pressure? B. A meta-analysis of controlled trials. Circulation 88 (1993) 523-533
16. Svaneborg N., Moller J.M., Schmidt E.B., Varming K., Lervang H.H., and Dyerberg J. The acute effects of a single very high dose of n-3 fatty acids on plasma lipids and lipoproteins in healthy subjects. Lipids 29 (1994) 145-147
17. Schacky C.V., Siess W., Fischer S., and Weber P.C. A comparative study of eicosapentaenoic acid metabolism by human platelets in vivo and in vitro. J Lipid Res 26 (1985) 457-464
18. Christensen J.H., Skou H.A., Madsen T., Torring I., and Schmidt E.B. Heart rate variability and n-3 polyunsaturated fatty acids in patients with diabetes mellitus. J Intern Med 249 (2001) 545-552
19. Li D., Yu X.M., Xie H.B., Zhang Y., Wang Q., Zhou X., et al. Platelet phospholipids n-3 PUFA negatively associated with plasma homocysteine in middle aged and geriatric hyperlipaemia patients. Prostaglandins Leukot Essent Fatty Acids 76 (2007) 293-297
20. Li D., Mann N.J., and Sinclair A.J. A significant inverse relationship between concentrations of plasma homocysteine and phospholipid docosahexaenoic acid in healthy male subjects. Lipids 41 (2006) 85-89
21. Zeman M., Žák A., Vecka M., Tvrzická E., Písaříková A., and Staňková B. N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combination. J Nutr Biochem 17 (2006) 379-384
22. Grundt H., Nilsen D.W., Mansoor M.A., Hetland O., and Nordoy A. Reduction in homocysteine by n-3 polyunsaturated fatty acids after 1 year in a randomised double-blind study following an acute myocardial infarction: no effect on endothelial adhesion properties. Pathophysiol Haemost Thromb 33 (2003) 88-95
23. Michele T.S., Richard A.L., David H., Joaquin C., Rebecca M.H., Sridevi D., and Ishwarlal J. Hyperhomocysteinemia measured by immunoassay: a valid measure of coronary artery atherosclerosis. Arch Pathol Lab Med 128 (2004) 1263-1266
24. Pascal P., Elisabeth L., and Michel V. Evaluation of the AxSYM homocysteine assay and comparison with the IMx homocysteine assay. Clin Chem 46 (2000) 1440-1441
25. Li D., Sinclair A.J., Mann N., Turner A., Ball M., Kelly F., et al. The effect of habitual diet on the thrombotic risk factors in healthy male subjects. Eur J Clin Nutr 53 (1999) 612-619
26. Cabrero C., Puerta J., and Alemany S. Purification and comparison of two forms of S-adenosyl-L-methionine synthetase from rat liver. Eur J Biochem 170 (1987) 299-304
27. Hultberg B., Andersson A., and Isaksson A. Copper ions differ from other thiol reactive metal ions in their effects on the concentration and redox status of thiols in Hela cell cultures. Toxicology 117 (1997) 89-97
28. Miller J.W., Nadeau M.R., Smith D., and Selhub J. Folate-deficiency-induced homocysteinaemia in rats: disruption of S-adenosylmethionine's co-ordinate regulation of homocysteine metabolism. Biochem J 298 (1994) 415-419
29. 2S generated by heart in rat and its effects on cardiac function. Biochem Biophys Res Commun 2 (2004) 362-368
30. Iso H., Kobayashi M., Ishihara J., Sasaki S., Okada K., Kita Y., et al. Intake of fish and n-3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) study cohort I. Circulation 113 (2006) 195-202
31. Olszewski A.J., and McCully K.S. Fish oil decreases serum homocysteine in hyperlipemic men. Coron Artery Dis 4 (1993) 53-60
32. Grundt H., Nilsen D.W.T., Hetland A., Mansoor M.A., Aarsland T., and Woie L. Atherothrombogenic risk modulation by n-3 fatty acids was not associated with changes in homocysteine in subjects with combined hyperlipidaemia. Thromb Haemost 81 (1999) 561-566
33. Nordstrom M., and Kjellstrom T. Age dependency of cystathionine beta-synthase activity in human fibroblasts in homocyst(e)inemia and atherosclerotic vascular disease. Atherosclerosis 94 (1992) 213-221
34. 12, serum total homocysteine levels in confirmed Alzheimer's disease. Arch Neurol 55 (1998) 1449-1455
35. Ravaglia G., Forti P., Maioli F., Martelli M., Servadei L., Brunetti N., et al. Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr 82 (2005) 636-643
36. Mudd S.H., Finkelstein J.D., Irreverre F., and Laster L. Homocystinuria: an enzymatic defect. Science 143 (1964) 1443-1445
37. 12 in vascular dementia and in Alzheimer disease. Clin Biochem 40 (2007) 859-863
38. 12 binding by transcobalamin II increased the risk of neural tube defects. Q J Med 94 (2001) 159-166
39. Bottiglieri T. Homocysteine and folate metabolism in depression. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 1103-1112
40. Homocysteine Lowering Trialists Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomized trials. Br Med J 316 (1998) 894-898
41. Jacques P.F., Sclhub J., Bostom A.G., Wilson P.W.F., and Rosenberg J.H. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 340 (1999) 49-54
42. Reguera R.M., Redondo C.M., Pérez-Pertejo Y., and Balaña-Fouce R. S-adenosylmethionine in protozoan parasites: functions, synthesis and regulation. Mol Biochem Parasitol 152 (2007) 1-10
43. Hamre M.R., Clark S.H., and Mirkin B.L. Resistance to inhibitors of S-adenosyl-L-homocysteine hydrolase in C1300 murine neuroblastoma tumor cells is associated with increased methionine adenosyltransferase activity. Oncol Res 7 (1995) 487-492
44. Dwivedi R.S., Wang L.J., and Mirkin B.L. S-adenosylmethionine synthetase is overexpressed in murine neuroblastoma cells resistant to nucleoside analogue inhibitors of S-adenosylhomocysteine hydrolase: a novel mechanism of drug resistance. Cancer Res 59 (1999) 1852-1856
45. Finkelstein J.D. Pathways and regulation of homocysteine metabolism in mammals. Semin Thromb Hemost 26 (2000) 219-225
46. Finkelstein J.D., and Martin J.J. Methionine metabolism in mammals: distribution of homocysteine between competing pathways. J Biol Chem 259 (1984) 9508-9513
47. James S.J., Melnyk S., Pogribna M., Pogribny I.P., and Caudill M.A. Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J Nutr 132 (2002) 2361S-2366S
48. Finkelstein J.D. The metabolism of homocysteine: pathways and regulation. Eur J Pediatr 157 (1998) S40-S44
49. Diwakar L., and Ravindranath V. Inhibition of cystathionine-γ-lyase leads to loss of glutathione and aggravation of mitochondrial dysfunction mediated by excitatory amino acid in the CNS. Neurochem Int 50 (2007) 418-426
50. Green P.S., Mendez A.J., Jacob J.S., Growdon W., Hyman B.T., and Heinecke J.W. Neuronal expression of myeloperoxidase isincreased in Alzheimer's disease. J Neurochem 90 (2004) 724-733
51. Chen L., Ingrid S., Ding Y.G., Liu Y., Qi J.G., Tang C.S., and Du J.B. Imbalance of endogenous homocysteine and hydrogen sulfide metabolic pathway in essential hypertensive children. Chin Med J 120 (2007) 389-393
52. Wang Y.F., Shi L., Du J.B., and Tang C.S. Impact of L-arginine on hydrogen sulfide/cystathionine-γ-lyase pathway in rats with high blood flow-induced pulmonary hypertension. Biochem Biophy Res Commun 345 (2006) 851-857